John D. Mahan, MD

John D. Mahan, MD, is the Program Director for the Nationwide Children’s Hospital/ The Ohio State University(OSU) Pediatric Residency Program and a Professor of Pediatrics at The Ohio State University (OSU) College of Medicine. Additionally, he is Program Director of the Pediatric Nephrology fellowship program. Dr. Mahan received his medical degree from Hahnemann Medical College. His clinical interests include pediatric dialysis and renal transplantation, growth failure in children with chronic kidney disease, treatments of hemolytic uremic syndrome and glomerulonephritis and metabolic bone disorders in children. His research interests are primarily associated with emerging therapies in pediatric dialysis and renal transplantation, growth hormone therapy in children with chronic kidney disease, bisphosphonate therapy in children with metabolic bone disease and osteoporosis and advances in learning technology in medical education. Dr. Mahan is principal investigator in a study of the effectiveness of recombinant growth hormone in treatment of growth failure in children with osteogenesis imperfecta on bisphosphonate therapy. He is a co-investigator in two National Institutes of Health-sponsored clinical trials: treatment of children with FSGS and the prospective study of chronic kidney disease in children. He is a principal investigator or co-investigator in eight active studies devoted to treatments in children with renal transplantation, metabolic bone disease and hypertension. Dr. Mahan also serves as chairman of the Post-Doctoral Education Committee for the Department of Pediatrics, the Nationwide Children’s Hospital Library Committee and the Medical Advisory Board of the National Kidney Foundation of Ohio. He is an elected board member of the Association of Pediatric Program Directors.

Gender:

• Male

Languages Spoken:

• English

Research Funding*:

• Safety and Efficacy of Nutropin AQ in Children with OI and IJO, Anonymous
• Zoledronic Acid, Anonymous

Medical School

• Hahnemann Medical College of Philadelphia
  Date Completed: 06/30/1977

Internship

• University of Minnesota Hospitals and Clinics
  Date Completed: 06/30/1978

Residency

• University of Minnesota Hospitals and Clinics
  Date Completed: 06/30/1981

Fellowship

• University of Minnesota Hospitals and Clinics
  Date Completed: 06/30/1984

Department:

• Pediatrics

Section:

• Nephrology

Speciality:

• Pediatric Nephrology
  
• Pediatrics
  

Date of Appointment at Nationwide Children’s Hospital:

• 09/25/1984

• Janjua HS, Mahan JD, Patel HP, Mentser M, Schwaderer AL. 2011. Continuous infusion of a standard combination solution in the management of hyperkalemia.  Nephrololgy Dialysis and Transplantation.
• Mahan JD. 2011. Nephrology and Urology. In Nelson - Essentials of Pediatrics. sixth ed. Edited by Marcdante KJ, Kliegman RM, Jenson HB, Behrman RE. Philadelphia, PA: Saunders.
• Spencer JD, Bates CM, Mahan JD, Niland ML, Staker SR, Hains DS, Schwaderer AL. 2011. The accuracy and health risks of a voiding cystourethrogram after a febrile urinary tract infection.  Jouranl of Pediatric Urology.
• Nailescu C, Xu X, Zhou H, Hall H, Wilson AC, Leiser JD, Chand DH, Valentini RP, Hebert D, Mahan JD. 2011. Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study.  Pediatric Nephrolology. Vol. 26, no. January: 459-467.
• Janjua HS, Mahan JD. 2011. The role and future challenges for recombinant growth hormone therapy to promote growth in children after renal transplantation.  Clinical Transplantation.
• Mahan JD, Ferris ME. 2010. Case-based education at the 2009 Pediatric Nephrology Fellows Conference.  Renal Failure. Vol. 32, no. January: 14-20.
• Iorember FM, Patel HP, Ohana A, Hayes JR, Mahan JD, Baker PB, Rajab A. 2010. Steroid avoidance using sirolimus and cyclosporine in pediatric renal transplantation: One year analysis.  Pediatr Transplant. Vol. 14, no. January: 83-99.
• Bowden SA and Mahan JD. 2010. Bone health in children with neuromuscular disorders: current opinions and future directions.  Pediatric Health. Vol. 4, no. January: 463-465.
• Weinstein AR, Reidy K, Norwood VF, Mahan JD. 2010. Factors influencing pediatric nephrology trainee entry into the workforce.  Clinical Journal of the American Society of Nephrology. Vol. 5, no. January: 1770-1774.
• Malik V, Rodino-Klapac LR, Viollet L, Wall C, King W, Al-Dahhak R, Lewis S, Shilling CJ, Kota J, Serrano-Munuera C, Hayes J, Mahan JD, Campbell KJ, Banwell B, Dasouki M, Watts V, Sivakumar K, Bien-Willner R, Flanigan KM, Sahenk Z, Barohn RJ, Walker CM, Mendell JR. 2010. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy.  Annals of Neurology. Vol. 67, no. January: 771-780.
• Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJ, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL. 2010. Fluid Overload and Mortality in Children Receiving Continuous Renal Replacement Therapy: The Prospective Pediatric Continuous Renal Replacement Therapy Registry.  Am J Kidney Dis. Vol. 55, no. January: 316-325.
• Roberto AJ, Goodall CE, West PM, Mahan JD. 2010. Persuading physicians to test their patients’ level of kidney functioning: the effects of message frame and point of view.  Health Communications. Vol. 25, no. January: 107-118.
• Mahan JD, Warady BA, Frane J, Rosenfeld RG, Swinford RD, Lippe B, Davis DA. 2010. First-year response to rhGH therapy in children with CKD: a National Cooperative Growth Study Report.  Pediatric Nephrology. Vol. 25, no. January: 1125-1130.
• Gipson DS; Massengill SF; Yao L; Nagaraj S; Smoyer WE; Mahan JD; Wigfall D; Miles P; Powell L; Lin JJ; Trachtman H; Greenbaum LA. 2009. Management of childhood onset nephrotic syndrome.  Pediatrics. Vol. 124, no. 2. (August): 747-757.
• Ferris ME; Mahan JD. 2009. Pediatric chronic kidney disease and the process of health care transition.  Seminars In Nephrology. Vol. 29, no. 4. (July): e435.
• Kerlin BA; Blatt NB; Fuh B; Zhao S; Lehman A; Blanchong C; Mahan JD; Smoyer WE. 2009. Epidemiology and risk factors for thromboembolic complications of childhood nephrotic syndrome: a Midwest Pediatric Nephrology Consortium (MWPNC) study.  The Journal Of Pediatrics. Vol. 155, no. 1. (July): 105-110.
• MacHardy N, Miles PV, Massengill SF, Smoyer WE, Mahan JD, Greenbaum L, Massie S, Yao L, Nagaraj S, Lin JJ, Wigfall D, Trachtman H, Hu Y, Gipson DS. 2009. Management patterns of childhood-onset nephrotic syndrome.  Pediatr Nephrol. Vol. 24, no. January: 2193-2201.
• Viollet L, Gailey S, Thornton DJ, Friedman NR, Flanigan KM, Mahan JD, Mendell JR. 2009. Utility of cystatin C to monitor renal function in Duchenne muscular dystrophy.  Muscle Nerve. Vol. 40, no. January: 432-442.
• Mahan JD, Smoyer WE. 2009. The need for a children's oncology group-oriented approach to advance the care of children with Idiopathic nephrotic syndrome.  Clin J Am Soc Nephrol. Vol. 4, no. January: 1549-1550.
• Meade M, Tornichio S, Mahan JD. 2009. Chronic Renal Disease. In Behavioral Approaches to Chronic Disease in Adolescence. Edited by O'Donohue WT, Tolle LW. Seacaucus, NJ: Springer.
• Batisky DL. Robinson RF, Mahan JD. 2009. Treatment of Childhood Hypertension. In Comprehensive Pediatric Nephrology. Edited by Geary DF, Schaefer F. Philadelphia, PA: Mosby Elsevier.
• Mahan JD. 2009. Growth Hormone. In Textbook of Nephro-Endocrinology. Edited by Singh AK, Williams GH. San Diego, CA: Academic Press.
• Schwaderer AL; Cronin R; Mahan JD; Bates CM. 2008. Low bone density in children with hypercalciuria and/or nephrolithiasis.  Pediatric Nephrology (Berlin, Germany). Vol. 23, no. 12. (December): e2209.
• Mahan JD; Patel HP. 2008. Recent advances in pediatric dialysis: a review of selected articles.  Pediatric Nephrology (Berlin, Germany). Vol. 23, no. 10. (October): e1737.
• Greenbaum LA; Hidalgo G; Chand D; Chiang M; Dell K; Kump T; Peschansky L; Smith HK; Boyle M; Kopf M; Metz LC; Kamel M; Mahan JD. 2008. Obstacles to the prescribing of growth hormone in children with chronic kidney disease.  Pediatric Nephrology (Berlin, Germany). Vol. 23, no. 9. (September): e1531.
• Bowden SA; Robinson RF; Carr R; Mahan JD. 2008. Prevalence of vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis referred to a pediatric metabolic bone clinic.  Pediatrics. Vol. 121, no. 6. (June): ee1585.
• Ettenger R; Hoyer PF; Grimm P; Webb N; Loirat C; Mahan JD; Mentser M; Niaudet P; Offner G; Vandamme-Lombaerts R; Hexham JM. 2008. Multicenter trial of everolimus in pediatric renal transplant recipients: results at three year.  Pediatric Transplantation. Vol. 12, no. 4. (June): e456.
• Flores FX; Brophy PD; Symons JM; Fortenberry JD; Chua AN; Alexander SR; Mahan JD; Bunchman TE; Blowey D; Somers MJ; Baum M; Hackbarth R; Chand D; McBryde K; Benfield M; Goldstein SL. 2008. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group.  Pediatric Nephrology (Berlin, Germany). Vol. 23, no. 4. (April): e625.
• Yeager ND, Hammond S, Mahan J, Davis JT, Adler B. 2008. Unique diagnostic features and successful management of a patient with disseminated lymphangiomatosis and chylothorax.  J Pediatr Hematol Oncol. Vol. 30, no. 1. (January): 66-69.
• Hackbarth R; Bunchman TE; Chua AN; Somers MJ; Baum M; Symons JM; Brophy PD; Blowey D; Fortenberry JD; Chand D; Flores FX; Alexander SR; Mahan JD; McBryde KD; Benfield MR; Goldstein SL. 2007. The effect of vascular access location and size on circuit survival in pediatric continuous renal replacement therapy: a report from the PPCRRT registry.  The International Journal Of Artificial Organs. Vol. 30, no. 12. (December): e1116.
• Symons JM; Chua AN; Somers MJ; Baum MA; Bunchman TE; Benfield MR; Brophy PD; Blowey D; Fortenberry JD; Chand D; Flores FX; Hackbarth R; Alexander SR; Mahan J; McBryde KD; Goldstein SL. 2007. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry.  Clinical Journal Of The American Society Of Nephrology: CJASN. Vol. 2, no. 4. (July): e732.
• Patel HP; Goldstein SL; Mahan JD; Smith B; Fried CB; Currier H; Flynn JT. 2007. A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients.  Clinical Journal Of The American Society Of Nephrology: CJASN. Vol. 2, no. 2. (March): e252.
• Fuh B, Kerlin B, Blanchong C, Blatt N, Zhoa S, Thornton J, Monda K, Smoyer W, Mahan J. 2007. Incidence and Risk Factors of Deep Venous Thrombosis in Children with Nephrotic Syndrome.  E-PAS. Vol. 61, no. January: e5873.
• Robinson RF; Morosco RS; Smith CV; Mahan JD. 2006. Stability of cefazolin sodium in four heparinized and non-heparinized dialysate solutions at 38 degrees C.  Peritoneal Dialysis International: Journal Of The International Society For Peritoneal Dialysis. Vol. 26, no. 5. (September): e593.
• Flynn JT; Nahata MC; Mahan JD Jr; Portman RJ. 2006. Population pharmacokinetics of amlodipine in hypertensive children and adolescents.  Journal Of Clinical Pharmacology. Vol. 46, no. 8. (August): e905.
• Mahan JD; Warady BA. 2006. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement.  Pediatric Nephrology (Berlin, Germany). Vol. 21, no. 7. (July): e917.
• Mahan JD. 2006. Applying the Growth Failure in CKD Consensus Conference: evaluation and treatment algorithm in children with chronic kidney disease.  Growth Hormone & IGF Research: Official Journal Of The Growth Hormone Research Society And The International IGF Research Society. Vol. 16 Suppl A, no. July: eS68.
• Stojanovski SD; Robinson RF; Baker SD; Casavant MJ; Hayes JR; Nahata MC. 2006. Children and adolescent exposures to atomoxetine hydrochloride reported to a poison control center.  Clinical Toxicology (Philadelphia, Pa.). Vol. 44, no. 3. (January): e243.
• Robinson RF; Batisky DL; Hayes JR; Nahata MC; Mahan JD. 2005. Significance of heritability in primary and secondary pediatric hypertension.  American Journal Of Hypertension. Vol. 18, no. 7. (July): e917.
• Robinson RF; Nahata MC; Batisky DL; Mahan JD. 2005. Pharmacologic treatment of chronic pediatric hypertension.  Paediatric Drugs. Vol. 7, no. 1. (January): e27.
• Robinson RF; Nahata MC; Sparks E; Daniels C; Batisky DL; Hayes JR; Mahan JD. 2005. Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients.  Pediatric Nephrology (Berlin, Germany). Vol. 20, no. 1. (January): e64.
• Robinson RF; Batisky DL; Hayes JR; Nahata MC; Mahan JD. 2004. Body mass index in primary and secondary pediatric hypertension.  Pediatric Nephrology (Berlin, Germany). Vol. 19, no. 12. (December): e1379.
• Robinson RF; Long LD; Mahan JD. 2004. Treatment of poor linear growth in a patient with osteogenesis imperfecta type III.  Clinical Therapeutics. Vol. 26, no. 10. (October): e1680.
• Johnson CE; Hurtubise LC; Castrop J; French G; Groner J; Ladinsky M; McLaughlin D; Plachta L; Mahan JD. 2004. Learning management systems: technology to measure the medical knowledge competency of the ACGME.  Medical Education. Vol. 38, no. 6. (June): e599.
• Robinson RF; Griffith JR; Nahata MC; Mahan JD; Casavant MJ. 2004. Herbal weight-loss supplement misadventures per a regional poison center.  The Annals Of Pharmacotherapy. Vol. 38, no. 5. (May): e787.
• Robinson RE; Nahata MC; Hayes JR; Batisky DL; Bates CM; Mahan JD. 2004. Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents.  Pharmacotherapy. Vol. 24, no. 2. (February): e195.
• Robinson RF; Casavant MJ; Nahata MC; Mahan JD. 2004. Metabolic bone disease after chronic antacid administration in an infant.  The Annals Of Pharmacotherapy. Vol. 38, no. 2. (February): e265.
• Robinson RF; Koranyi K; Mahan JD; Nahata MC. 2004. Increased frequency of acute mastoiditis in children.  American Journal Of Health-System Pharmacy: AJHP: Official Journal Of The American Society Of Health-System Pharmacists. Vol. 61, no. 3. (February): e304.
• Goldstein SL; Somers MJ; Brophy PD; Bunchman TE; Baum M; Blowey D; Mahan JD; Flores FX; Fortenberry JD; Chua A; Alexander SR; Hackbarth R; Symons JM. 2004. The Prospective Pediatric Continuous Renal Replacement Therapy (ppCRRT) Registry: design, development and data assessed.  The International Journal Of Artificial Organs. Vol. 27, no. 1. (January): e9.
• Chan JC; Mahan JD; Trachtman H; Scheinman J; Flynn JT; Alon US; Lande MB; Weiss RA; Norkus EP. 2003. Vitamin E therapy in IgA nephropathy: a double-blind, placebo-controlled study.  Pediatric Nephrology (Berlin, Germany). Vol. 18, no. 10. (October): e1015.
• Robinson RF; Nahata MC; Mahan JD; Batisky DL. 2003. Management of nephrotic syndrome in children.  Pharmacotherapy. Vol. 23, no. 8. (August): e1021.
• Hoyer PF; Ettenger R; Kovarik JM; Webb NJ; Lemire J; Mentser M; Mahan J; Loirat C; Niaudet P; VanDamme-Lombaerts R; Offner G; Wehr S; Moeller V; Mayer H. 2003. Everolimus in pediatric de nova renal transplant patients.  Transplantation. Vol. 75, no. 12. (June): e2082.
• Trachtman H; Frank R; Mahan JD; Portman R; Restaino I; Matoo TK; Tou C; Klibaner M. 2003. Clinical trial of extended-release felodipine in pediatric essential hypertension.  Pediatric Nephrology (Berlin, Germany). Vol. 18, no. 6. (June): e548.
• Van Damme-Lombaerts R; Webb NA; Hoyer PF; Mahan J; Lemire J; Ettenger R; McMahon L; Cambon N; Boger R; Kovarik JM. 2002. Single-dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients.  Pediatric Transplantation. Vol. 6, no. 2. (April): e147.
• Kari JA; Bamashmous H; Mahan JD. 2002. Steroid-sensitive nephrotic syndrome and juvenile idiopathic arthritis.  Pediatric Nephrology (Berlin, Germany). Vol. 17, no. 11. (January): e975.
• Hebert LA; Agarwal G; Sedmak DD; Mahan JD; Becker W; Nagaraja HN. 2000. Proximal tubular epithelial hyperplasia in patients with chronic glomerular proteinuria.  Kidney International. Vol. 57, no. 5. (May): e1962.
• McCarthy DW; Mutabagani K; Mahan JD; Caniano DA; Cooney DR. 2000. Infarction of the choledochus, liver, gallbladder, and pancreas: a unique complication of the hemolytic uremic syndrome.  Journal Of Pediatric Surgery. Vol. 35, no. 3. (March): e502.
• Ward-Cook KM; Mahan JD; Frenchko CE; Albright A; Chiasera JM; McAllister C. 1999. Anionic charge sites in the kidney: comparison of two diabetic rat models.  Annals Of Clinical And Laboratory Science. Vol. 29, no. 4. (October): e286.
• Tallian KB; Nahata MC; Turman MA; Mahan JD; Hayes JR; Mentser MI. 1999. Efficacy of amlodipine in pediatric patients with hypertension.  Pediatric Nephrology (Berlin, Germany). Vol. 13, no. 4. (May): e304.
• Mahan JD; Turman MA; Mentser MI. 1997. Evaluation of hematuria, proteinuria, and hypertension in adolescents.  Pediatric Clinics Of North America. Vol. 44, no. 6. (December): e1573.
• Hebert LA; Birmingham DJ; Mahan JD; Cosio FG; Dillon JJ; Sedmak DD; Shen XP; McAllister C. 1997. Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate.  American Journal Of Kidney Diseases: The Official Journal Of The National Kidney Foundation. Vol. 30, no. 2. (August): e243.
• van Setten PA; van Hinsbergh VW; van der Velden TJ; van de Kar NC; Vermeer M; Mahan JD; Assmann KJ; van den Heuvel LP; Monnens LA. 1997. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.  Kidney International. Vol. 51, no. 4. (April): e1245.
• Cromer BA; Blair JM; Mahan JD; Zibners L; Naumovski Z. 1996. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.  The Journal Of Pediatrics. Vol. 129, no. 5. (November): e671.
• Albright AL; Mahan JD; Ward KM; Sherman WM; Roehrig KL; Kirby TE. 1995. Diabetic nephropathy in an aerobically trained rat model of diabetes.  Medicine And Science In Sports And Exercise. Vol. 27, no. 9. (September): e1270.
• Mentser M; Mahan J; Koff S. 1995. Contemporary approaches to renovascular hypertension in children.  Pediatric Nephrology (Berlin, Germany). Vol. 9, no. 3. (June): e386.
• Mahan JD; Mentser MI; Koff SA. 1994. Complications of intestinal augmentation and substitution cystoplasty.  Pediatric Nephrology (Berlin, Germany). Vol. 8, no. 4. (August): e505.
• Ward KM; Mahan JD; Sherman WM. 1994. Aerobic training and diabetic nephropathy in the obese Zucker rat.  Annals Of Clinical And Laboratory Science. Vol. 24, no. 3. (May): e266.
• Hebert LA; Birmingham DJ; Mahan JD; Shen XP; McAllister C; Cosio FG; Dillon JJ. 1994. Effect of chronically increased erythrocyte complement receptors on immune complex nephritis.  Kidney International. Vol. 45, no. 2. (February): e493.
• Menster M; Mahan J; Koff S. 1994. Multicystic dysplastic kidney.  Pediatric Nephrology (Berlin, Germany). Vol. 8, no. 1. (February): e113.
• Hajinazarian M; Cosio FG; Nahman NS Jr; Mahan JD. 1994. Angiotensin-converting enzyme inhibition partially prevents diabetic organomegaly.  American Journal Of Kidney Diseases: The Official Journal Of The National Kidney Foundation. Vol. 23, no. 1. (January): e105.
• Mahan JD; Hebert LA; McAllister C; Birmingham DJ; Shen XP; Cosio FG; Brandt J. 1993. Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate.  Kidney International. Vol. 44, no. 4. (October): e716.
• Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JA. 1992. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.  The Annals Of Pharmacotherapy. Vol. 26, no. 3. (March): e341.
• Hebert LA; Cosio FG; Birmingham DJ; Mahan JD. 1991. Biologic significance of the erythrocyte complement receptor: a primate perquisite.  The Journal Of Laboratory And Clinical Medicine. Vol. 118, no. 4. (October): e301.
• Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW. 1991. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.  Antimicrobial Agents And Chemotherapy. Vol. 35, no. 9. (September): e1879.
• Sentipal JM; Wardlaw GM; Mahan J; Matkovic V. 1991. Influence of calcium intake and growth indexes on vertebral bone mineral density in young females.  The American Journal Of Clinical Nutrition. Vol. 54, no. 2. (August): e425.
• Southard RN; Morris JD; Mahan JD; Hayes JR; Torch MA; Sommer A; Zipf WB. 1991. Bone mass in healthy children: measurement with quantitative DXA.  Radiology. Vol. 179, no. 3. (June): e735.
• Hebert LA; Cosio FG; Birmingham DJ; Mahan JD; Sharma HM; Smead WL; Goel R. 1991. Experimental immune complex-mediated glomerulonephritis in the nonhuman primate.  Kidney International. Vol. 39, no. 1. (January): e44.
• Cosio FG; Bakaletz AP; Mahan JD. 1990. Role of precipitating and nonprecipitating antibodies in glomerular immune complex formation.  Kidney International. Vol. 37, no. 6. (June): e1429.
• Cosio FG; Mahan JD; Sedmak DD. 1990. Experimental glomerulonephritis induced by antigen that binds to glomerular fibronectin.  American Journal Of Kidney Diseases: The Official Journal Of The National Kidney Foundation. Vol. 15, no. 2. (February): e160.
• Seifert-McLean CM; Cromer BA; Mosher G; Mahan JD. 1989. Urinary calcium excretion in healthy adolescents.  Journal Of Adolescent Health Care: Official Publication Of The Society For Adolescent Medicine. Vol. 10, no. 4. (July): e300.
• Cosio FG; Sedmak DD; Mahan JD; Nahman NS Jr. 1989. Localization of decay accelerating factor in normal and diseased kidneys.  Kidney International. Vol. 36, no. 1. (July): e100.
• Waller KV; Ward KM; Mahan JD; Wismatt DK. 1989. Current concepts in proteinuria.  Clinical Chemistry. Vol. 35, no. 5. (May): e755.
• Mahan JD; Sisson-Ross SS; Vernier RL. 1989. Anionic sites in the human kidney: ex vivo perfusion studies.  Modern Pathology: An Official Journal Of The United States And Canadian Academy Of Pathology, Inc. Vol. 2, no. 2. (March): e117.
• Hamoudi AC; Mahan JD; Westman JA; Sommer A. 1989. 4(del p) syndrome and cytomegalovirus.  Pediatric Pathology / Affiliated With The International Paediatric Pathology Association. Vol. 9, no. 2. (January): e231.
• Nahman NS Jr; Cosio FG; Mahan JD; Henry ML; Ferguson RM. 1988. Cyclosporine nephrotoxicity in spontaneously hypertensive rats.  Transplantation. Vol. 45, no. 4. (April): e768.
• Cosio FG; Innes JT; Nahman NS Jr; Mahan JD; Ferguson RM. 1987. Combined nephrotoxic effects of cyclosporine and endotoxin.  Transplantation. Vol. 44, no. 3. (September): e425.
• Mahan JD; Sisson-Ross S; Vernier RL. 1986. Glomerular basement membrane anionic charge site changes early in aminonucleoside nephrosis.  The American Journal Of Pathology. Vol. 125, no. 2. (November): e393.
• Shore RM; Koff SA; Hayes JR; Smith SP; Mentser M; Mahan JD. 1986. Glomerular filtration rate in children: validation and longitudinal use of determination from the 99mTc DTPA renogram.  American Journal Of Kidney Diseases: The Official Journal Of The National Kidney Foundation. Vol. 8, no. 3. (September): e170.
• Fowler A; Mahan JD Jr; Nevins TE. 1984. The Hickman catheter--today's vascular access for pediatric hemodialysis.  ANNA Journal / American Nephrology Nurses' Association. Vol. 11, no. 7. (December): e36.
• Mahan JD; Mauer SM; Sibley RK; Vernier RL. 1984. Congenital nephrotic syndrome: evolution of medical management and results of renal transplantation.  The Journal Of Pediatrics. Vol. 105, no. 4. (October): e549.
• So SK; Mahan JD Jr; Mauer SM; Sutherland DE; Nevins TE. 1984. Hickman catheter for pediatric hemodialysis: a 3-year experience.  Transactions - American Society For Artificial Internal Organs. Vol. 30, no. January: e619.
• Mahan JD Jr; Mauer SM; Nevins TE. 1983. The Hickman catheter: a new hemodialysis access device for infants and small children.  Kidney International. Vol. 24, no. 5. (November): e694.
• Vernier RL; Klein DJ; Sisson SP; Mahan JD; Oegema TR; Brown DM. 1983. Heparan sulfate--rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome.  The New England Journal Of Medicine. Vol. 309, no. 17. (January): e1001.
• Patel HP, Goldstein SL, Mahan JD, Smith B, Fried CB, Currier H, Flynn JT. A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. Clinical Journal of the American Society of Nephrology 2(2): 252-7, 2007 (Epub, January 31, 2007).
• Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clinical Journal of the American Society of Nephrology 2(4): 732-8, 2007 (Epub, May 18, 2007).

• Listed, Best Doctors in America